These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37829474)

  • 1. ＜Editors' Choice＞ Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia.
    Kata Y; Hara Y; Murohashi K; Saigusa Y; Nagasawa R; Tagami Y; Fujii H; Aoki A; Nishikawa Y; Tanaka K; Watanabe K; Horita N; Kobayashi N; Yamamoto M; Kudo M; Kaneko T
    Nagoya J Med Sci; 2023 Aug; 85(3):602-611. PubMed ID: 37829474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.
    Murohashi K; Hara Y; Saigusa Y; Kobayashi N; Sato T; Yamamoto M; Kudo M; Kaneko T
    J Thorac Dis; 2019 Jun; 11(6):2448-2457. PubMed ID: 31372282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
    Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
    Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study.
    Kato M; Yamada T; Kataoka S; Arai Y; Miura K; Ochi Y; Ihara H; Koyama R; Sasaki S; Takahashi K
    Respir Res; 2019 Dec; 20(1):287. PubMed ID: 31852459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.
    Park IN; Kim DS; Shim TS; Lim CM; Lee SD; Koh Y; Kim WS; Kim WD; Jang SJ; Colby TV
    Chest; 2007 Jul; 132(1):214-20. PubMed ID: 17400667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases.
    Suda T; Kaida Y; Nakamura Y; Enomoto N; Fujisawa T; Imokawa S; Hashizume H; Naito T; Hashimoto D; Takehara Y; Inui N; Nakamura H; Colby TV; Chida K
    Respir Med; 2009 Jun; 103(6):846-53. PubMed ID: 19181509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.
    Maeda H; Kanzaki M; Sakamoto K; Isaka T; Oyama K; Murasugi M; Onuki T
    Surg Today; 2017 Sep; 47(9):1072-1079. PubMed ID: 28247107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias.
    Arai T; Tachibana K; Sugimoto C; Inoue Y; Tokura S; Okuma T; Akira M; Kitaichi M; Hayashi S; Inoue Y
    Respirology; 2017 Oct; 22(7):1363-1370. PubMed ID: 28508494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin.
    Arai T; Matsuoka H; Hirose M; Kida H; Yamamoto S; Ogata Y; Mori M; Hatsuda K; Sugimoto C; Tachibana K; Akira M; Inoue Y
    BMJ Open Respir Res; 2021 Jul; 8(1):. PubMed ID: 34326155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of a composite scoring system including Charlson Comorbidity Index score in patients with interstitial lung disease.
    Yagyu H; Murohashi K; Hara Y; Saigusa Y; Aoki A; Kobayashi N; Kaneko T
    J Thorac Dis; 2020 Oct; 12(10):5774-5782. PubMed ID: 33209409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
    Karayama M; Aoshima Y; Suzuki T; Mori K; Yoshizawa N; Ichikawa S; Kato S; Yokomura K; Kono M; Hashimoto D; Inoue Y; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Goshima S; Inui N; Suda T
    Eur Respir J; 2023 May; 61(5):. PubMed ID: 36822633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and subacute idiopathic interstitial pneumonias.
    Taniguchi H; Kondoh Y
    Respirology; 2016 Jul; 21(5):810-20. PubMed ID: 27123874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroradiologic prognostic evaluation of acute exacerbation in patients with idiopathic interstitial pneumonia: a retrospective observational study.
    Arai T; Akira M; Sugimoto C; Tachibana K; Inoue Y; Shintani S; Okuma T; Kasai T; Hayashi S; Inoue Y
    J Thorac Dis; 2020 Aug; 12(8):4132-4147. PubMed ID: 32944325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
    Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of direct hemoperfusion with a polymyxin B immobilized fiber column in acute exacerbation of interstitial pneumonia and serum indicators].
    Miyamoto K; Tasaka S; Hasegawa N; Kamata H; Shinoda H; Kimizuka Y; Fujiwara H; Kotake Y; Takeda J; Ishizaka A
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):978-84. PubMed ID: 19994591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocytapheresis for the treatment of acute exacerbation of idiopathic interstitial pneumonias: a pilot study.
    Yamamoto A; Hashimoto K; Yamasaki A; Takata M; Morita M; Funaki Y; Okada K; Teruya Y; Fukushima T; Shimizu E
    J Med Invest; 2017; 64(1.2):110-116. PubMed ID: 28373606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of diagnostic utility of serum hemeoxygenase-1 measurement for acute exacerbation of interstitial pneumonias.
    Kata Y; Hara Y; Tagami Y; Yabe A; Murohashi K; Nagasawa R; Nakashima K; Fujii H; Saigusa Y; Shiida M; Watanabe K; Horita N; Kobayashi N; Kaneko T
    Sci Rep; 2022 Jul; 12(1):12935. PubMed ID: 35902685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of pulmonary hypertension and its clinical relevance in patients with interstitial pneumonias: comparison between idiopathic and collagen vascular disease associated interstitial pneumonias.
    Handa T; Nagai S; Miki S; Ueda S; Yukawa N; Fushimi Y; Ito Y; Ohta K; Mimori T; Mishima M; Izumi T
    Intern Med; 2007; 46(12):831-7. PubMed ID: 17575374
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Akaike K; Saruwatari K; Sakata S; Oda S; Shiraishi S; Iyama S; Masunaga A; Tomita Y; Ichiyasu H; Sakagami T
    Respirol Case Rep; 2024 Jul; 12(7):e01427. PubMed ID: 39006515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.